|
|
Structure |
Product Information |
|
AKA002
21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo- [635-65-4] |
|
AKA008
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic acid deriv. [33069-62-4] |
|
AKA011
1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl- [83-67-0] |
|
AKA014
Benzeneacetonitrile, ¦Á-[(6-O-¦Â-D-glucopyranosyl-¦Â-D-glucopyranosyl)oxy]- [29883-15-6] |
|
AKD002
2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro- [479-41-4] |
|
AKD003
Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)- [518-17-2] |
|
AKD004
Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13-dihydro- [84-26-4] |
|
AKD005
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16¦Á,17¦Á)- [146-48-5] |
|
AKP001
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aS,13aR,13bR,13cS)- [519-02-8] |
|
AKP002
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, 4-oxide, (4R,7aS,13aR,13bR,13cS)- [16837-52-8] |
|
AKP003
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, 2,3,6,7,7a,8,13,13a,13b,13c-decahydro-, (7aS,13aR,13bR,13cS)- [6483-15-4] |
|
AKP004
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aR,13aR,13bR,13cS)- [6882-68-4] |
|
AKP005
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, 4-oxide, (7aR,13aR,13bR,13cS)- [54809-74-4] |
|
AKP016
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5S)- [19130-96-2] |
|
AKQ010
Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy- [2086-83-1] |
|
AKQ011
6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride (1:1) [6024-85-7] |
|
AKQ012
Dibenzo[a,g]quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, chloride (1:1) [10605-02-4] |
|
AKQ024
Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, (9¦Á,13¦Á,14¦Á)- [115-53-7] |
|
AQA002
9,10-Anthracenedione, 1,8-dihydroxy-3-methyl- [481-74-3] |
|
AQA003
9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)- [481-72-1] |
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. |
|
New Arrival
|